MYC and lymphoma: Inactivating MYC is sufficient to induce cancer regression in diverse models of MYC‐driven cancer lymphoma, skin papilloma, and osteosarcoma, a phenomenon known as ‘oncogene addiction’ [16, 22, 120, 121, 122, 123, 124].